Pharmafile Logo
Pharmafocus logo
Advanced Search

breast cancer

Showing 15 posts of 167 posts found.

shutterstock_212035546

Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk

July 9, 2018
Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …

News
roche__tree

Roche’s Tecentriq combo gives strong Phase 3 showing in triple negative breast cancer

July 2, 2018
Research and Development, Sales and Marketing Cancer, Roche, breast cancer, pharma

Roche has unveiled new Phase 3 data on its immunotherapy drug Tecentriq (atezolizumab) in combination with chemotherapy (Celgene’s Abraxane) as …

News
astrazeneca-sign

AstraZeneca chalks up double Japanese approval in lung and breast cancer

July 2, 2018
Sales and Marketing AstraZeneca, Cancer, Imfinzi, NSCLD, breast cancer, lung cancer, lynparza, pharma

It’s a big step forward for AstraZeneca’s global marketing operations as the company announced that two of its products have …

News
pfizerbrussels_web

Pfizer’s Ibrance combo fails to improve overall survival in HER2- metastatic breast cancer

June 26, 2018
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Faslodex, Pfizer, breast cancer, ibrance, pharma

Pfizer has stumbled with the reveal of new data on the efficacy of its oral CDK 4/6 inhibitor Ibrance (palbociclib) in combination …

News
rocherooflr

NICE turns down Roche’s Perjeta for post-surgery HER2-positive breast cancer

June 15, 2018
Medical Communications, Sales and Marketing Cancer, NICE, Perjeta, Roche, breast cancer, pharma

Roche’s ongoing dispute with UK health service watchdog NICE over the availability of its monoclonal antibody Perjeta (pertuzumab) on the …

News
roche

Roche’s breast, lung cancer offerings fail to impress at ASCO

June 4, 2018
Research and Development, Sales and Marketing ASCO, Cancer, Roche, breast cancer, lung cancer, pharma, taselisib, tecentriq

Roche made an underwhelming impact at the American Society of Clinical Oncology (ASCO) annual event in Chicago, after revealing data …

News

EMA’s CHMP backs Roche’s Perjeta combo in HER2-positive breast cancer

April 30, 2018
Sales and Marketing Cancer, Herceptin, Perjeta, Roche, breast cancer, pharma

Roche’s Perjeta has edged one step closer to approval as a combo therapy after the EMA’s Committee for Medicinal Products …

News
shutterstock_159488225

Promising drug for hormone therapy-resistant breast cancer enters human trials

March 22, 2018
Research and Development TTC-352, breast cancer, chicago, pharma

A team of researchers at Chicago’s University of Illinois (UIC) have revealed that their promising drug which could prove an …

News

FDA authorises first direct-to-consumer test for BRCA mutations, with caveats

March 6, 2018
Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma

The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …

News
shutterstock

Blood test could predict treatment effectiveness months earlier in breast cancer

March 6, 2018
Manufacturing and Production, Research and Development Cancer, ICR, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, breast cancer, palbociclib, pharma

A team of scientists at The Institute of Cancer Research in London and The Royal Marsden NHS Foundation Trust have …

News

FDA expands indication of Lilly’s Verzenio in advanced breast cancer

February 27, 2018
Manufacturing and Production, Sales and Marketing Cancer, Eli Lilly, FDA, Verzenio, breast cancer, pharma

Eli Lilly is celebrating the news that its cyclin-dependent kinase (CDK) 4 & 6 inhibitor Verzenio (ademaciclib) has received approval …

News
abbottweb

Abbott teams up with Angle for metastatic breast cancer study

February 6, 2018
Manufacturing and Production, Research and Development Abbott, Angle, Cancer, breast cancer, pharma

Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …

News
pink_ribbon

UK breast cancer mortality falls 10% over five years, overtaken by prostate deaths for first time

February 5, 2018
Research and Development, Sales and Marketing Cancer, Cancer Research UK, breast cancer, pharma, prostate cancer

Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …

News
breast_cancer_care

UK charity Breast Cancer Care receives £655,000 cash injection to expand end-of-treatment app

January 31, 2018
Research and Development Breast Cancer Care, National lottery, UK, breast cancer, charity, pharma

UK charity Breast Cancer Care (BCC) is set to expand the development of its end-of-treatment support app after receiving a …

News
fda2outsideweb

AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer

January 15, 2018
Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma

The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …

News

Latest content

FDA grants marketing authorisation to DNA test for predisposition to certain cancers

October 2, 2023

Biogen’s biosimilar Tofidence approved by FDA

October 2, 2023

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023